Evaluation of ABT-751 against childhood cancer models in vivo
Pharmacological profiling of novel non-COX-inhibiting indole-pyran analogues of etodolac reveals high solid tumour activity of SDX-308 in vitro
Taurolidine : A novel anti-neoplastic agent induces apoptosis of osteosarcoma cell lines
A thermally targeted elastin-like polypeptide-doxorubicin conjugate overcomes drug resistance
Human mass balance study of the novel anticancer agent ixabepilone using accelerator mass spectrometry
A phase I trial of BMS-247550 (NSC# 710428) and gemcitabine in patients with advanced solid tumors
Pro-apoptotic activity of imidazole derivatives mediated by up-regulation of Bax and activation of CAD in Ehrlich Ascites Tumor cells
Erlotinib and vinorelbine in advanced malignant solid tumors : A phase I study
A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomes
A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomas
Phase II study of CT-2103 as first- or second-line chemotherapy in patients with metastatic breast cancer : Unexpected incidence of hypersensitivity reactions
Phase II study of amrubicin, 9-amino-anthracycline, in patients with advanced non-small-cell lung cancer : A West Japan Thoracic Oncology Group (WJTOG) study
A randomised phase II study of OSI-7904L versus 5-fluorouracil (FU)/leucovorin (LV) as first-line treatment in patients with advanced biliary cancers
Simple, mammalian cell-based assay for identification of inhibitors of the Erk MAP kinase pathway
Antitumor activity of enzastaurin (LY317615.HCl) against human cancer cell lines and freshly explanted tumors investigated in in-vitro soft-agar cloning experiments